Rarebase

Rarebase Remarks Episode #1 – Lynsey Chediak: Never give up

Jan 24, 2022

Rarebase Team

Lynsey Chediak is Rarebase’s Head of Impact and Patient Experience. She was born with a rare genetic bone and joint disease called arthrogryposis. Formerly, she led the inaugural precision medicine portfolio at the World Economic Forum. She is also the Founder and CEO of a rare disease patient advocacy non-profit, working to increase patient engagement across pediatric hospitals in the USA.

In Episode #1 of Rarebase Remarks, Lynsey shares her own experience with rare disease, her many professional contributions to the community, and her goals at Rarebase.

Sources

Next Up

Rarebase

Rarebase Remarks Episode #1 – Lynsey Chediak: Never give up

Sources

Next Up

3,700 disease-causing genes: Our plan to fill the void in rare disease drug discovery

Reimagining rare disease research: The science & technology behind Rarebase

How does Rarebase identify drug repurposing candidates for rare genetic diseases?

Rarebase Remarks Episode #4 - Clayton Mellina: Engineering and AI in the biotech space

Onno Faber Selected for Worth Magazine’s Worthy 100 2022 List

Rarebase Is on the Hunt for Therapeutic Opportunities (Illumina)

He Got A Rare Disease Diagnosis So He Rethought The Whole System (Worth)

Video: Drug discovery for rare diseases

Rarebase Remarks Episode #2 - Chris Moxham: Drug hunting for rare disease

Celebrating Our Second Anniversary

Fundraising best practices for rare disease foundations

Using mathematics to provide a rare disease roadmap

A path forward, for one or for many

Rarebase Remarks Episode #1 – Lynsey Chediak: Never give up

The Champion for Rare Disease Cures (neo.life)

Rarebase launches a neuroscience drug discovery platform collaborating with 15 rare disease patient organizations

What does it mean to find a “cure” for a disease?

It’s Monday. It’s still Rare Disease Day.

Translating science into therapies, for one or for many.